Six Indian pharmaceutical manufacturers choose rfxcel

rfxcel has more than doubled its annual sales performance in India and in the Asia-Pacific

rfxcel, a provider of track and trace solutions for the pharmaceutical market, has announced growth in India. rfxcel has more than doubled its annual sales performance in India and in Asia-Pacific.

"Our rapid growth in India is the result of our dominant position in the serialization platform space and our emergence as the leader in track and trace technologies. Through our focus on customer success and product innovation, we have become the trusted global traceability standard for more than 300 brands," said Vikash Pushpraj, Senior VP of rfxcel.

"In the past year, we have invested heavily in building traceability technology critical for regulatory compliance and supply chain visibility. As a result, we have emerged as the essential traceability platform, focused on full-service on-boarding, 24/7 support and the platform for true data integrity."

Traceability is the primary focus for the life sciences in 2018. According to a rfxcel customer survey of 100+ brands, 89% believe collaboration, full-service onboarding, continued support, and interoperability are important for a successful and secure supply chain.

According to the rfxcel, it is the first-ever traceability platform to help companies of all sizes and industries easily connect and integrate with trading partners, resulting in predictable outcomes and lower supply chain costs.

"rfxcel's unwavering commitment to our success has enabled us to grow our serialization program and engage our trading partners more effectively," said a CIO at one of India largest pharmaceutical companies based in Mumbai, India. "rfxcel is an innovative company delivering cutting-edge technology and data-driven intelligence that we can leverage in our programs."